Richmond Pharmacology

News

Further data to be presented at The 32nd Annual Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT) Following Richmond Pharmacology’s Chief Executive Officer and...
Read More

Cardiac Safety

 

Cardiac Safety Solutions at Richmond Pharmacology


As the UK’s leading early phase specialists, we know how important safety is to our sponsors and to our volunteers. It’s no surprise that Richmond Pharmacology’s Cardiac Safety Solutions are trusted worldwide.


Not only do we have the latest technology for  ECG and Holter recording and analysis, our team of highly experienced cardiologists and under-one-roof core ECG lab ensure that all data collected is 100% accurate and regulatory compliant whilst maintaining the highest level of cardiac safety.


As our patient volunteer database has grown to over 100,000 registrations coupled with our extensive experience in Thorough QT Studies, we understand that it’s paramount to both our sponsors and volunteers that all cardiac safety studies conducted at Richmond Pharmacology are perfectly executed, every time. Our core ECG lab provides a centralised system for all our cardiac safety trials. It has the longstanding commercial, clinical and academic reputation of excellence of St Georges University of London reflected in the higher number of publications originating from this centre of excellence. As you would expect, it utilises the latest FDA and ICH GCP compliant digital 12 lead ECG and holter devices, but more importantly, the data gathered is analysed by our own cardiologists. Our approach is holistic and we will get to the heart of any issue identified. This ensures nothing is missed and the cardiac rhythm information is accurate and correctly interpreted.

 

Reasons why you can truly rely on Richmond Pharmacology to deliver accurate and the highest standards of cardiac safety testing.

 

  • Our Expertise

    You can trust our 100% success rate when planning and carrying out your testing.

    We have never conducted a TQT which has shown a false positive result. Not only do we know what to do, we know how to do it and that is proven by 100% of our case studies showing assay sensitivity, in other words they just don't go wrong.

  • Under one roof approach

    Our ECGs are renowned to be the best in the industry as certified by the global ECG core laboratory of a top 10 pharmaceutical company. 

    We believe this is owing to our unique under 1 roof approach where the recording of our ECGs is supervised by people who will later read them i.e. the cardiologists.

  • Geographic Location

    An FDA compliant study in the US? Think twice. All our studies were submitted to the FDA (U.S. Food and Drug Administration), MHRA (Medicines and Healthcare products Regulatory Agency) and MHLW (Japanese Ministry of Health, Labour and Welfare). Who said you have to conduct a study in the country of targeted submission?

  • Lower Cost

    Our Thorough QT studies are 100% successful – that has to be cheaper than repeating the exercise again.

    At Richmond Pharmacology, we get it right the first time so there will never be a second time. We have your financial interests at heart too and will only sell you what you need. Guaranteed.

We are market leaders in delivering dependable cardiac safety solutions with each study, take a look for yourself:

MEET THE EXPERTS

Richmond Pharmacology's people have extensive knowledge and expertise.

A DECADE OF EXCELLENCE

 

Proud to be celebrating
10 years of clinical
excellence…


Learn More

WE RISE TO THE CHALLENGE

 

We know we can help your
business. We always rise
to the challenge…


Challenge Us
© 2012 Richmond Pharmacology. All rights reserved  |  disclaimer  |  site map
clinical trials london | clinical jobs